An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Carolyn A. Thomson and Kathy D. McCoy | Aug 1, 2021 | 10+ min read
Bacteria in the gut influence the production of antibodies and themselves secrete metabolites. In a pregnant woman, these compounds may influence immune development of her fetus.
When I was a high school student, I came across Erwin Schrödingers What Is Life?. I still remember my exultant reaction—a combination of adolescent pride in feeling able to understand ideas considered beyond a young person’s means, and a genuine intellectual thrill engendered by the problems that Schrödinger addressed. Upon rereading the book, it appears to me that its major value was to provoke interest in a central problem of biology. Schrödinger’s question
As more researchers flock to the popular field, observers fear a widening gap between supply and demand When scientists convene in New Orleans next week for the 33rd annual meeting of the American Society for Cell Biology (ASCB), nine symposia, 20 minisymposia, and countless informal gatherings are sure to focus on the recent achievements and continuing progress in this exciting and rapidly expanding scientific field. There is likely to be little excitement in the air, however, concerning the
Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.